Insight Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,786
Closed -$219K 254
2026
Q1
$219K Buy
+7,786
New +$207K 0.04% 223
2025
Q4
Sell
-8,219
Closed -$210K 298
2025
Q3
$210K Buy
+8,219
New +$203K 0.03% 268
2025
Q2
Sell
-8,477
Closed -$215K 305
2025
Q1
$215K Buy
+8,477
New +$222K 0.04% 264
2024
Q4
Sell
-55,678
Closed -$1.61M 306
2024
Q3
$1.61M Sell
55,678
-767
-1% -$22.4K 0.28% 60
2024
Q2
$1.58M Buy
56,445
+19
+0% +$523 0.29% 59
2024
Q1
$1.57M Buy
56,426
+2,066
+4% +$57.3K 0.3% 58
2023
Q4
$1.57M Buy
54,360
+15,304
+39% +$463K 0.33% 52
2023
Q3
$1.3M Sell
39,056
-553
-1% -$19.6K 0.3% 58
2023
Q2
$1.45M Sell
39,609
-72
-0.2% -$2.8K 0.32% 49
2023
Q1
$1.62M Buy
39,681
+27,711
+232% +$1.2M 0.38% 40
2022
Q4
$614K Sell
11,970
-27
-0.2% -$1.29K 0.21% 123
2022
Q3
$525K Sell
11,997
-296
-2% -$14.4K 0.21% 127
2022
Q2
$616K Sell
12,293
-606
-5% -$30.9K 0.21% 124
2022
Q1
$668K Buy
12,899
+1,606
+14% +$83.3K 0.2% 131
2021
Q4
$667K Sell
11,293
-193
-2% -$9.56K 0.2% 124
2021
Q3
$504K Sell
11,486
-815
-7% -$36.1K 0.15% 172
2021
Q2
$541K Sell
12,301
-4,460
-27% -$173K 0.17% 157
2021
Q1
$652K Sell
16,761
-171
-1% -$6.07K 0.21% 129
2020
Q4
$623K Buy
+16,932
New +$621K 0.24% 110

Other funds holding PFE

Insight Advisors's PFE Position: Q2 2026 in Review

Insight Advisors sold out of Pfizer (PFE) in Q2 2026, closing a stake of 7,786 shares — an estimated $219K sold.

Insight Advisors first reported a position in PFE in Q4 2020 and held it in 19 quarters. The position peaked at $1.62M in Q1 2023. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Insight Advisors reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Insight Advisors sold 7,786 Pfizer shares in Q2 2026, an estimated $219K.
  • Insight Advisors first reported a position in Pfizer in Q4 2020 and held it in 19 quarters.
  • Insight Advisors's Pfizer position peaked at $1.62M in Q1 2023.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Insight Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.